Abstract
Bradley’s (1937) seminal publication of the ameliorative effects of Benzedrine on behavior-disordered children had significant impact on pediatric psychopharmacology and to a large extent altered child psychiatric and neurological services in this country. According to Bradley and his colleagues, the main clinical effects of stimulant drugs were reduced hyperactivity, distractibility, and impulsivity in children who had not responded to traditional psychotherapy. Ironically, Bradley’s earlier clinical observations, which were based on insufficient investigation and inadequate methodology, are generally consistent with contemporary research findings, which generally support the efficacy of stimulants in improving performance on a wide array of cognitive tasks and decreasing disruptive behaviors (Gittelman, 1983).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abikoff, H., and Gittelman, R. (1985). Hyperactive children treated with stimulants: Is cognitive training a useful adjunct? Archives of General Psychiatry, 42, 953–961.
Abikoff, H., Gittelman-Klein, R., and Klein, D. F. (1977). Validation of a classroom observation code for hyperactive children. Journal of Consulting and Clinical Psychology, 45, 77 2783.
Adams, W. (1982). Effect of methylphenidate on thought processing time in children. Developmental and Behavioral Pediatrics. 3, 133–135.
Allen, R. P., and Safer, D. (1979). Long-term effects of stimulant therapy for HA children: Risk benefits analysis. In M. J. Cohen (Ed.), Drugs and the special child (pp. 189–202 ). New York: Gardner.
Aman, M. G. (1982a). Psychotropic drugs in the treatment of reading disorders. In R. N. Malatesha and P. G. Aaron (Eds.), Reading disorders: Varieties and treatments (pp. 453–471 ). New York: Academic Press.
Aman, M. G. (1982b). Stimulant drug effects in developmental disorders and hyperactivity-Toward a resolution of disparate findings. Journal of Austism and Developmental Disorders, 12, 385–398.
Aman, M. G., and Sprague, R. L. (1974). The state-dependent effects of methylphenidate and dextroamphetamine. Journal of Nervous and Mental Disease, /58, 268–279.
Aman, M. G., and Werry, J. S. (1982). Methylphenidate and diazepam in severe reading retardation. Journal of the American Academy of Child Psychiatry, 1, 31–37.
American Academy of Pediatrics, Council on Child Health. (1975). Medication for hyperkinetic children. Pediatrics, 55, 560–561.
American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders ( 3rd ed. ). Washington, DC: Author.
Arnold, L. E., Christopher, J., and Huestis, R. (1978). Methylphenidate vs. dextroamphetamine vs. caffeine in minimal brain dysfunction. Archives of General Psychiatry, 35, 463–473.
Bandura, A., Jeffrey, R. W., and Gajdos, E. (1975). Generalizing change through participant modeling with self-directed mastery. Behavior Research and Therapy, 13, 141–152.
Barcai, A. (1971). Predicting the response of children with learning disabilities and behavior problems to dextroamphetamine sulfate. Pediatrics, 47, 73–80.
Barkley, R. A. (1976). Predicting the response of hyperkinetic children to stimulant drugs: A review. Journal of Abnormal Child Psychology, 4, 327–348.
Barkley, R. A. (1977). The effects of methylphenidate on various measures of activity level and attention in hyperkinetic children. Journal of Abnormal Child Psychology, 5, 351–369.
Barkley, R. A. (1981). Hyperactive children: A handbook for diagnosis and treatment. New York: Guilford Press.
Barkley, R. A., Karlsson, J., Pollard, S., and Murphy, J. V. (1985). Developmental changes in the mother-child interactions of hyperactive boys: Effects of two dose levels of Ritalin. Journal of Child Psychology and Psychiatry, 24, 705–715.
Blouin, A. G. A., Bornstein, R. A., and Trites, R. L. (1978). Teenage alcohol use among hyperactive children: A five-year follow-up study. Journal of Pediatric Psychology, 3, 188194.
Blunden, D., Spring, C., and Greenberg, L. (1974). Validation of the classroom behavior inventory. Journal of Consulting and Clinical Psychology, 42, 84–88.
Boileau, R. A., Ballard, J. E., Sprague, R. L., Sleator, E. K., and Massey, B. H. (1976). Effect of methylphenidate on cardiorespiratory responses in hyperactive children. Research Quarterly, 47, 590–596.
Borden, K. A. (1986). Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Un-published doctoral dissertation, University of Illinois, Urbana-Champaign.
Bosco, J. J., and Robin, S. S. (1980). Hyperkinesis: Prevalence and treatment. In C. K. Whalen and B. Henker (Eds.), Hyperactive children (pp. 173–187 ). New York: Academic Press.
Bradley, C. (1937). The behavior of children receiving Ben- zedrine. American Journal of Psychiatry, 94, 577–585.
Brown, R. T., Borden, K. A., and Clingerman, S. R. (1985). Adherence to methylphenidate therapy in a pediatric population: A preliminary investigation. Psychopharmacology Bulletin, 21, 28–36.
Brown, R. T., Borden, K. A., Spunt, A. L., and Medenis, R. (1985). Depression following pemoline withdrawal in a hy- peractive child [letter]. Clinical Pediatrics, 24, 174–175.
Brown, R. T., Borden, K. A., Wynne, M. E., Clingerman, S. R., and Spunt, A. (1987). An examination of compliance with pharmacological and cognitive treatments for attention deficit disorder. American Academy of Child and Adolescent Psychiatry, 26, 521–526.
Brown, R. T., Borden, K. A., Wynne, M. A., Schiesser, R., and Clingerman, S. R. (1986). Methylphenidate and cognitive therapy with ADD children: A methodological reconsideration. Journal of Abnormal Child Psychology, 4, 481–497.
Brown, R. T., and Sexson, S. B. ( 1986, August). Methylphenidate in the treatment of ADD adolescents. Paper presented at the annual meeting of the American Psychological Association. Washington, DC.
Brown, R. T., and Sleator, E. K. (1979). Methylphenidate in hyper-kinetic children: Differences in dose effects on impulsive behavior. Pediatrics, 64, 408–411.
Brown, R. T., Slimmer, L., and Wynne, M. E. (1984). How much stimulant medication is appropriate for hyperactive school children? Journal of School Health, 54, 128–130.
Brown, R. T., Wynne, M. E., and Medenis, R. (1985). Methylphenidate and cognitive therapy: A comparison of treatment approaches with hyperactive boys. Journal ofAbnormal Child Psychology, 13, 69–87.
Bryan, T. H., and Bryan, J. H. (1978). Understanding learning disabilities. Palo Alto, CA: Alfred.
Bugenthal, D. B., Whalen, C. K., and Henker, B. (1977). Causal attributions of hyperactive children and motivational assumptions of two behavior change approaches: Evidence for an interactionist position. Child Development, 48, 874–884.
Campbell, S. B., Endman, M. W., and Bernfeld, G. (1977). A three-year follow-up of hyperactive preschoolers into elementary school. Journal of Child Psychology and Psychiatry, 18, 239–249.
Cantwell, D. P. (1979). Use of stimulant medication with psychiatrically disordered adolescents. Adolescent Psychiatry, 7, 375–388.
Cantwell, D. P. (1985). Pharmacotherapy of ADD in adolescence: What do we know, where should we go, how should we do it?
Psychopharmacology Bulletin, 21, 251–257.
Cantwell, D. P., and Carlson, G. A. (1978). Stimulants. In J. S.
Werry (Ed.), Pediatric psychopharmacology: The use of behavior-modifying drugs in children (pp. 171–207). New York: Brunner/Mazel.
Chamberlin, R. W. (1974). Convulsions and Ritalin? [Letter]. Pediatrics, 54, 658–659.
Chan, Y.-P. M., Swanson, J. M., Soldin, S. S., Thiessen, J. J., MacLeod, S. M., and Logan, W. (1983). Methylphenidate hydrochloride given with or before breakfast. Il. Effects on plasma concentration of methylphenidate and ritalinic acid. Pediatrics, 72, 56–59.
Charles, L., Schain, R., and Zelniker, T. (1981). Optimal dosages of methylphenidate for improving the learning and behavior of hyperactive children. Developmental and Behavioral Pediatrics, 2, 78–81.
Clampit, M. K., and Pirkle, J. B. (1983). Stimulant medication and the hyperactive adolescent: Myths and facts. Adolescence, 18, 811–822.
Close, J. (1973). Scored neurological examination. Psychopharmacology Bulletin, 9, 142–148.
Conners, C. K. (1969). A teacher rating scale for use in drug studies with children. American Journal of Psychiatry, 126, 152–156.
Conners, C. K. (1971). Recent drug studies with hyperkinetic children. Journal of Learning Disabilities, 4, 476–483.
Conners, C. K. (1972). Psychological effects of stimulant drugs in children with minimal brain dysfunction. Pediatrics, 49, 702–708.
Conners, C. K. (1973, September). A Clinical comparison of methylphenidate and placebo in the treatment of children with minimal brain dysfunction. Paper presented at the annual meeting of the American Psychological Association, Montreal, Canada.
Conners, C. K., and Eisenberg, L. (1963). The effects of methylphenidate on symptomatology and learning in disturbed children. American Journal of Psychiatry, 120, 458–464.
Conners, C. K., and Taylor, E. (1980). Pemoline, methylphenidate, and placebo in children with minimal brain dysfunction. Archives of General Psychiatry, 37, 922–930.
Coons, H. W., Klorman, R., and Borgstedt, A. D. (1987). Enhancing effects of methylphenidate on sustained attention and event-related potentials of adolescent patients with attention deficit disorders. Psychophysiology, 24, 572–573.
Coons, H. W., Peloquin, L., and Klorman, R. (1981). Effect of methylphenidate on young adults’ vigilance and event related potentials. Electroencephalography and Clinical Neurophysiology, 51, 373–387.
Cutler, M., Little, J. W., and Strauss, A. A. (1940). The effect of Benzedrine on mentally deficient children. American Journal of Mental Deficiency, 45, 49–65.
Donchin, E., Ritter, W., and McCallum, W. C. (1978). Cognitive psychophysiology: The endogenous components of the ERP. In E. Callaway, P. Tueting, and S. H. Koslow (Eds.), Event-related potentials in man (pp. 349–411 ). New York: Academic Press.
Donnelly, M., and Rapoport, J. L. (1985). Attention deficit disorders. In J. M. Wiener (Ed.), Diagnosis and psychopharmacology of childhood and adolescent disorders (pp. 179–197 ). New York: Wiley.
Douglas, V. I. (1980). Treatment and training approaches to hyperactivity: Establishing internal or external control. In C. K. Whalen and B. Henker (Eds.), Hyperactive children: The social ecology of identification and treatment (pp. 283–317 ). New York: Academic Press.
Douglas, V. I., Barr, R. G., O’Neill, M. E., and Britton, B. G. (1986). Short-term effects of methylphenidate on the cognitive, learning and academic performance of children with attention deficit disorder in the laboratory and classroom. Journal of Child Psychology and Psychiatry, 27, 191–211.
Douglas, V. I., and Peters, K. G. (1979). Toward a clearer defini-tion of the attentional deficit of hyperactive children. In G. A. Hale and M. Lewis (Eds.), Attention and the development of cognitive skills (pp. 173–247 ). New York: Plenum Press.
Dulcan, M. K. (1985). Attention deficit disorder: Evaluation and treatment. Pediatric Annals, 14, 383–398.
Dulcan, M. K. (1986). Comprehensive treatment of children and adolescents with attention deficit disorders: The state of the art. Clinical Psychology Review, 6, 539–569.
Dykman, R., Ackerman, P. T., and Oglesby, C. (1979). Selective and sustained attention in hyperactive, learning-disabled, and normal boys. Journal of Nervous and Mental Disease, 167, 288–297.
Edelbrock, C., and Rancurello, M. (1985). Assessment of childhood hyperactivity: Rating scales and their applications. Clinical Psychology Review, 5, 429–445.
Eisenberg, L. (1972). The hyperkinetic child and stimulant drugs. New England Journal of Medicine, 287, 249–250.
Eisenberg, L., Lachman, R., Moiling, P. A., Lockner, A., Mizelle, J. D., and Conners, C. K. (1963). A psychopharmacological experiment in a training school for delinquent boys: Methods, problems, findings. American Journal of Orthopsychiatry, 33, 431–447.
Firestone, P. (1982). Factors associated with children’s adherence to stimulant medication. American Journal of Orthopsychiatry, 52, 447–457.
Fish, B. (1971). The “one child, one drug” myth of stimulants in hyperkinesis. Archives of General Psychiatry, 25, 193–203. Fisher, K. C., and Wilson, W. P. (1971). Methylphenidate and the hyperkinetic. Diseases of the Nervous System, 32, 695–698.
Gadow, K. D. (1981). Drug therapy for hyperactivity: Treatment procedures in natural settings. In K. D. Gadow and J. Loney (Eds.), Psychosocial aspects of drug treatment for hyperactivity (pp. 325–378 ). Boulder, CO: Westview.
Gadow, K. D. (1983). Pharmacotherapy for behavior disorders: Typical treatment practices. Clinical Pediatrics, 22, 48–53.
Gadow, K. D. (1985a). Prevalence and efficacy of stimulant drug use with mentally retarded children and youth. Psychopharmacology Bulletin, 21, 291–303.
Gadow, K. D. (19856). Relative efficacy of pharmacological, behavioral, and combination treatments for enhancing academic performance. Clinical Psychology Review, 5,513533.
Gadow, K., and Sprague, R. L. ( 1980, September). An anterospecrive follow-up of hyperactive children into adolescence: Licit and illicit drug use. Paper presented at the annual meeting of the American Psychological Association, Montreal, Canada.
Gadow, K. D., and Swanson, H. L. (1985). Assessing drug effects on academic performance. Psychopharmacology Bulletin, 21, 877–886.
Gadow, K. D., Torgesen, J., Greenstein, J., and Schell, R. (1986). Learning disabilities. In M. Hersen and S. E. Breuning (Eds.), Pharmacological and behavioral treatment: An integrated approach (pp. 149–196 ). New York: Wiley.
Gan, J., and Cantwell, D. (1982). Dosage effects of methylphenidate on paired associate learning: Positive/negative placebo responders. Journal of the American Academy of Child Psychiatry, 21. 237–242.
Garfinkel, B. D. (1986). Recent developments in attention deficit disorder. Psychiatric Annals. 16. 11–15.
Garfinkel, B. D., Brown, W. A., Klee, S. H., Braden, W., Beauchesne, H., and Shapiro, S. K. (in press). Neuroendocrine and cognitive responses to amphetamine in adolescents with a history of ADD. Journal of Clinical Pharmacology.
Gilman, A. G., Goodman, L. S., andGilman, A. (1980). Goodman and Gilman’s the pharmacologic basis of therapeutics ( 6th ed. ). New York: Macmillan Co.
Gittelman, R. (1980). Indications for the use of stimulant treatment in learning disorders. Journal of the American Academy of Child Psychiatry, 19, 623–636.
Gittelman, R. (1982). Controlled study of methylphenidate in combination with academic instruction. Psychopharmacology Bulletin, 18, 112–113.
Gittelman, R. (1983). Hyperkinetic syndrome: Treatment issues and principles. In M. Rutter (Ed.), Developmental neuro-psychiatry (pp. 437–449 ). New York: Guilford Press.
Gittelman, R., Klein, D. F., and Feingold, I. (1983). Children with reading disorders. II. Effects of methylphenidate in combination with reading remediation. Journal of Child Psychology and Psychiatry, 24, 193–212.
Gittelman-Klein, R., and Klein, D. F. (1975). Are behavioral and psychometric changes related in methylphenidate-treated, hyperactive children? International Journal of Mental Health, 4, 182–198.
Gittelman-Klein, R., and Klein, D. F. (1976). Methylphenidate effects in learning disabilities: Psychometric changes. Archives of General Psychiatry 33655–664.
Gittelman-Klein, R., Klein, D., Katz, S., Saraf, K., and Pollack, E. (1976). Comparative effects of methylphenidate and thioridazine in hyperkinetic children. Archives of General Psychiatry, 33, 1217–1231.
Grimm, L. G. (1980). The maintenance of self-and drug-attributed behavior change: A critique. Journal of Abnormal Psychology, 89, 282–285.
Gross, M. D., and Wilson, N. C. (1974). Minimal brain dysfunction. New York: Brunner/Mazel.
Halliday, R. A., Rosenthal, J. H., Naylor, H., and Callaway, E. (1976). Average evoked potential predictors of clinical improvement in hyperactive children treated with methylphenidate: An initial study and replication. Psychophysiology, 13. 429–440.
Henker, B., and Whalen, C. K. (1980). The changing faces of hyperactivity: Retrospect and prospect. In C. K. Whalen and B. Henker (Eds.), Hyperactive children (pp. 321–363 ). New York: Academic Press.
Henker, B., Whalen, C. K., Bugenthal, D. B., and Barker, C. (1981). Licit and illicit drug patterns in stimulant treated children and their peers. In K. D. Gadow and J. Loney (Eds.), Psychosocial aspects of drug treatment for hyperactivity (pp. 443–462 ). Boulder, CO: Westview.
Hinshaw, S. P., Henker, B., and Whalen, C. K. (1984). Self-control in hyperactive boys in anger-inducing situations: Effects of cognitive-behavioral training and methylphenidate. Journal of Abnormal Child Psychology, 52, 739–749.
Hoy, E., Weiss, G., Minde, K., and Cohen, N. (1978). The hyperactive child at adolescence: Cognitive, emotional, and social functioning. Journal of Abnormal Child Psychology, 6, 31 1324.
Huddleston, W., Staiger, R. C., Frye, R., Musgrave, R. S., and Stritch, T. (1961). Deanol as aid in overcoming reading retardation. Clinical Medicine. 8, 1340–1342.
Huessey, H. R., Cohen, S. M., Blair, C. L., and Wood, P. (1979). Clinical explorations in adult minimal brain dysfunction. In L. Bellak (Ed.), Psychiatric aspects of minimal brain dysfunction (pp. 19–36 ). New York: Grune and Stratton.
Huey, L. Y. (1985). Attention deficit disorders. In R. Michaels, J. O. Cavenar, K. H. Brodie, A. M. Cooper, S. B. Guze, L. L. Judd, G. L. Klerman, and A. J. Solnit (Eds.), Psychiatry (Vol. 3, pp. 1–31 ). Philadelphia: Lippincott.
Kagan, J. (1965). Reflection-impulsivity and reading ability in primary grade children. Child Development, 36, 609–628.
Kalachnik, J. E., Sprague, R. L., Sleator, E. K., Cohen, M. N., and Ullmann, R. K. (1981). Use of the RWT stature prediction formula in monitoring growth suppression effects in methylphenidate. Unpublished manuscript, University of Illinois.
Kaufman, A. S. (1979). Intelligence testing with the WISC-R. New York: Wiley.
Kavale, K. (1982). The efficacy of stimulant drug treatment for hyperactivity: A meta-analysis. Journal of Learning Disabilities, 15, 280–289.
Kinsboume, M. (1973). Minimal brain dysfunction as a neurodevelopmental lag. Annals of the New York Academy of Sciences, 205, 263–273.
Kinsboume, M., and Swanson, J. M. (1980). Evaluation of symptomatic treatment of hyperactive behavior by stimulant drugs. In R. Knights and D. Bakker (Eds.), Treatment of hyperactive and learning disordered children (pp. 207–217 ). Baltimore: University Park Press.
Klee, S. H. (1986). The clinical psychological evaluation of atten- tion deficit disorder. Psychiatric Annals, 16, 43–46.
Klein, D. F., Gittelman, R., Quitkin, F., and Rifkin, A. (1980). Diagnosis and drug treatment of psychiatric disorders: Adults and children. Baltimore: Williams and Wilkins.
Klorman, R. (1986). Attention-deficit disorder in adolescents. In R. A. Feldman and A. R. Stiffman (Eds.), Advances in adolescent mental health. Greenwich, CT: JAI Press.
Korey, S. R. (1949). The effects of Benzedrine sulfate on the behavior of psychopathic and neurotic juvenile delinquents. Psychiatric Quarterly, 18, 127–137.
Laufer, M. W., Denhoff, E., and Solomon, G. (1957). Hyper-kinetic impulse disorder in children’s behavior problems. Psychosomatic Medicine, 19, 38–49.
Lerer, R. J., and Lerer, P. (1977). Response of adolescents with minimal brain dysfunction to methylphenidate. Journal of Learning Disabilities, 10, 35–40.
Lezak, M. D. (1983). Neuropsychological assessment. New York: Oxford University Press.
Loiselle, D., Stamm, J. S., Maitinsky, S., and Whipple, S. C. (1980). Evoked potential and behavioral signs of attention dysfunctions in hyperactive boys. Psychophysiology, 17, 193–201.
Loney, J. (1986). Predicting stimulant drug response among hyperactive children. Psychiatric Annals, 16, 16–19.
Loney, J., Kramer, J., and Milich, R. S. (1981). The hyperactive child grows up: Predictors of symptoms, delinquency and achievement at follow-up. In K. D. Gadow and J. Loney (Eds.), Psychosocial aspects of drug treatment for hyperactivity (pp. 381–415 ). Boulder, CO: Westview.
Loney, J., Whaley-Klahn, M. A., Porto, L. B., and Adney, K. (1981). Predictors of adolescent height and weight in hyper-kinetic boys treated with methylphenidate. Psychopharmacology Bulletin, 17. 132–134.
Lucas, A. R., and Weiss, M. (1971). Methylphenidate hallucinosis. Journal of the American Medical Association, 217, 1079 1081.
MacKay, M. C., Beck, L., and Taylor, R. (1973). Methylphenidate for adolescents with minimal brain dysfunction. New York State Journal of Medicine, 73, 550–554.
Maletzky, B. M. (1974). o-Amphetamine and delinquency: Hyperkinesis persisting? Diseases of the Nervous System, 35, 543–547.
Michael, R. L., Klorman, R., and Salzman, L. F. (1981). Normalizing effects of methylphenidate on hyperactive children’s vigilance performance and evoked potentials. Psychophysiology, 17, 193–201.
Mirsky, A. F., and Rosvold, H. E. (1963). Behavioral and physiological studies in impaired attention. In Z. Votava, M. Horvath, and O. Vinar (Eds.), Psychopharmacological methods: Proceedings of a symposium on the effects of psychotropic drugs on higher nervous activity (pp. 302–315). Elmsford, NY: Pergamon Press.
Molitch, M. J., and Sullivan, J. P. (1937). The effect of Benzedrine sulfate on children taking the new Stanford Achievement Test. American Journal of Orthopsychiatry, 7, 519–522.
Newell, G. R., and Henderson, B. E. (1973). Case-control study of Hodgkin’s disease. I. Results of the interview questionnaire. Journal of the National Cancer Institute, 51, 1437–1441.
O’Irary, K. D., Romanczyk, R. G., Kass, R. E., Dietz, A., and Santagrossi, D. (1971). Procedures for classroom observation of teachers and children. Unpublished manuscript, State University of New York, Stony Brook.
Page, J. G., Bernstein, J. E., Janicki, R. S., and Michelli, P. A. (1974). A multi-clinic trial of pemoline in childhood hyperkinesis. In C. K. Conners (Ed.), Clinical uses of stimulant drugs in children (pp. 98–129 ). Amsterdam: Excerpta Medica.
Pelham, W. E. (1980, September). Peer relationships in hyperactive children: Description and treatment effects. In R. Milich (Chair), Peer relationships among hyperactive children. Symposium conducted at the annual meeting of the American Psychological Association, Montreal, Canada.
Pelham, W. E., Bender, M. E., Caddell, J., Booth, S., and Moorer, S. H. (1985). Methylphenidate and children with attention deficit disorder: Dose effects on classroom academic and social behavior. Archives of General Psychiatry, 42, 948–952.
Pelham, W. E., and Murphy, H. A. (1986). Behavioral and pharmacological treatment of attention deficit and conduct disorders. In M. Hersen and S. E. Breuning (Eds.), Pharmacological and behavioral treatment: An integrative approach. New York: Wiley.
Poling, A., and Breuning, S. E. (1983). Effects of methylphenidate on the fixed-ration performance of mentally retarded children. Pharmacology, Biochemistry, and Behavior, 18, 53 1544.
Porrino, L. J., Rapoport, J. L., Behar, D., Ismond, D., and Bunney, W. E. (1983). A naturalistic assessment of the motor activity of hyperactive boys. Il. Stimulant drug effects. Archives of General Psychiatry, 40, 688–693.
Rapoport, J. L. (1983). The use of drugs: Trends in research. In M. Rutter (Ed.), Developmental neuropsychiatre (pp. 385403 ). New York: Guilford Press.
Rapoport, J., Quinn, P., Bradbard, G., Riddle, D., and Brooks, E. (1974). Imipramine and methylphenidate treatments of hyperactive boys. Archives of General Psychiatry, 30, 789793.
Rapport, M. D., DuPaul, G. J., Stoner, G., Birmingham, B. K., and Masse, G. (1985b). Attention deficit disorder with hyperactivity: Differential effects of methylphenidate on impulsivity. Pediatrics, 76, 938–943.
Rapport, M. D., Stoner, G., DuPaul, G. J., Birmingham, B. K., and Tucker, S. (1985). Methylphenidate in hyperactive children: Differential effects of dose on academic, learning, and social behavior. Journal of Abnormal Child Psychology, 13, 227–244.
Roche, A. F., Lipman, R. S., Overall, J. E., and Hung, W. (1979). The effects of stimulant medication on the growth of hyperactive children. Pediatrics, 63, 847–850.
Rosen. L. A., O’Leary, S. G., and Conway, G. (1985). The withdrawal of stimulant medication for hyperactivity: Overcoming detrimental attributions. Behavior Therapy, 16, 538544.
Rosenhan, D. L. (1973). On being sane in insane places. Science. 179, 250–258.
Rosenthal, R. H., and Allen, T. W. (1978). An examination of attention, arousal, and learning dysfunctions of hyperkinetic children. Psychological Bulletin, 85, 689–715.
Ross, D. M., and Ross, S. A. (1982). Hyperactivity. New York: Wiley.
Safer, D. J., and Allen, R. P. (1973). Factors influencing the suppressant effects of two stimulant drugs on the growth of hyperactive children. Pediatrics, 51, 660–667.
Safer, D. J., and Allen, R. P. (1975a). Side effects from long-term use of stimulants in children. In R. Gittelman-Klein (Ed.), Recent advances in child psychopharmacology (pp. 109122 ). New York: International Arts and Science Press.
Safer, D. J., and Allen, R. P. (1975b). Stimulant treatment of hyperactive adolescents. Diseases of the Nervous System, 36, 454457.
Safer, D., Allen, R., and Barr, E. (1972). Depression of growth in hyperactive children on stimulant drugs. New England Journal of Medicine, 287, 217–220.
Safer, D. J., Allen, R. P., and Barr, E. (1975). Growth rebound after termination of stimulant drugs. Journal of Pediatrics, 86, 113–116.
Safer, D. J., and Krager, J. M. (1985). Prevalence of medication treatment for hyperactive adolescents. Psychopharmacology Bulletin, 21, 212–221.
Sallee, F., Stiller, R., Perel, J., and Bates, T. (1985). Oral pemoline kinetics in hyperactive children. Clinical Pharmacology and Therapeutics, 37, 606–609.
Sandoval, J. (1977). Measurement of the hyperactive syndrome in children. Review of Educational Research, 47, 293–318.
Satterfield, J. H., Cantwell, D. P., and Satterfield, B. T. (1974). Pathophysiology of the hyperactive child syndrome. Archives of Genera! Psychiatry, 31, 839–844.
Satterfield, J. H., and Dawson, M. E. (1971). Electrodermal correlates of hyperactivity in children. Psychophysiology, 8, 19 1197.
Schleifer, M., Weiss, G., Cohen, N., Elman, M., Cvejic, H., and Kruger, E. (1975). Hyperactivity in preschoolers and the effect of methylphenidate. American Journal of Orthopsychiatry, 45, 38–50.
Shekim, W. O., Dekirmenjlan, H., and Chapel, J. L. (1979). Urinary MHPH excretion in minimal brain dysfunction in older children. American Journal of Psychiatry, 136, 667–671.
Sleator, E. K. (1980). Deleterious effects of drugs used for hyperactivity on patients with Gilles de la Tourette’s syndrome. Clinical Pediatrics, 19, 453–454.
Sleator, E. K. (1985). Measurement of compliance. Psychopharmacology Bulletin, 21, 1089–1093.
Sleator, E. K., Ullmann, R. K., and von Neumann, A. (1982). How do hyperactive children feel about taking stimulants and will they tell the doctor? Clinical Pediatrics, 21, 474–479.
Sleator, E. K., von Neumann, A., and Sprague, R. L. (1974). Hyperactive children: A continuous long-term placebo-controlled follow-up. Journal of the American Medical Association, 227, 316–327.
Solanto, M. V. (1984). Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: A review and synthesis. Psychological Bulletin, 95, 387–409.
Solomons, G. (1973). Drug therapy: Initiation and follow-up. Annals of the New York Academy of Sciences, 205, 335–344.
Sprague, R. L. (1977). Psychopharmacotherapy in children. In M. F. MacMillan and S. Henao (Eds.), Child psychiatry: Treatment and research. New York: Brunner/Mazel.
Sprague, R. L. (1983). Behavior modification and educational techniques. In M. Rutter (Ed.), Developmental neuro-psychiatry (pp. 404–421 ). New York: Guilford Press.
Sprague, R. L., and Berger, B. D. (1980)? Drug effects on learning performance: Relevance of animal research to pediatric psychopharmacology. In R. M. Knights and D. J. Bakker (Eds.), Rehabilitation, treatment and management of learning disorders (pp. 167–183). Baltimore: University Park Press.
Sprague, R. L., and Sleator, E. K. (1977). Methylphenidate in hyperkinetic children: Differences in dose effects on learning and social behavior. Science, 198, 1274–1276.
Stephens, R. S., Pelham, W. E., and Skinner, R. (1984). State-dependent and main effects of methylphenidate and pemoline on paired-associate learning and spelling in hyperactive chil- dren. Journal of Consulting and Clinical Psychology, 52, 104–113.
Surwillo, W. W. (1980). Changes in the electroencephalogram accompanying the use of stimulant drugs (methylphenidate and dextroamphetamine) in hyperactive children. Biological Psychiatry, 12, 787–799.
Swanson, J. M., and Kinsboume, M. (1976). Stimulant-related state-dependent learning in hyperactive children. Science, 192, 1354–1357.
Swanson, J. M., and Kinsboume, M. (1979). The cognitive effects of stimulant drugs on hyperactive (inattentive) children. In G. Hales and M. Lewis (Eds.), Attention and the development of cognitive skills (pp. 249–274 ). New York: Plenum Press.
Swanson, J., Kinsboume, M., Roberts, W., and Zucker, K. (1978). Dose response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity. Pediatrics, 61, 21–29.
Swanson, J., Sandman, C., Deutsch, C., and Baren, M. (1983). Methylphenidate hydrochloride given with or before break- fast. I. Behavioral, cognitive and electrophysiologic effects. Pediatrics, 72, 49–55.
Thorley, G. (1984). Review of follow-up and follow-back studies of childhood hyperactivity. Psychological Bulletin, 96, 116132.
Ullmann, R. K., and Sleator, E. K. (1985). Attention deficit disordered children with or without hyperactivity: Which behaviors are helped by stimulants? Clinical Pediatrics, 24, 547552.
Varley, C. K. (1983). Effects of methylphenidate in adolescents with attention deficit disorder. Journal of the American Academy of Child Psychiatry, 22, 351–354.
Varley, C. K. (1985). A review of studies of drug treatment efficacy for attention deficit disorder with hyperactivity in adolescents. Psychopharmacology Bulletin, 21, 216–221.
Varley, C. K., and Trupin, E. W. (1982). Double-blind administration of methylphenidate to mentally retarded children with attention deficit disorder: A preliminary study. American Journal of Mental Deficiency, 86, 560–566.
Volkmar, F. R., Hoder, E. L., and Cohen, D. J. (1985). Inappropriate uses of stimulant medication. Clinical Pediatrics, 24, 127–130.
Weingartner, H., Ebert, M. H., Mikkelsen, E. J., Rapoport, J. L., Buchsbaum, M. S., Bunney, W. E., and Caine, E. D. (1980). Cognitive processes in normal and hyperactive children and their response to amphetamine treatment. Journal of Abnormal Psychology, 89, 25–37.
Weiss, G. (1983). Long-term outcome: Findings, concepts, and practical implications. In M. Rutter (Ed.), Developmental neuropsychiatry (pp. 422–449 ). New York: Guilford Press.
Weiss, G., and Hechtman, L. T. (1979). The hyperactive child syndrome. Science, 205, 1348–1354.
Weiss, G., Hechtman, L., Hopkins, J., Perlman, T., and Wenar, A. (1979). Hyperactives as young adults: A controlled-perspective ten-year follow-up of 75 children. Archives of General Psychiatry, 36, 675–681.
Weiss, G., Kruger, E., Danielson, V., and Elman, J. (1975). Effects of long-term treatment of hyperactive children with methylphenidate. Canadian Medical Association Journal, 112, 159–165.
Weiss, G., Minde, K., Douglas, V., Werry, J., and Sykes, D. (1971). Comparison of the effect of chloropromazine, dextroamphetamine, and methylphenidate on the behavior and intellectual functioning of hyperactive children. Canadian Medical Association Journal, 104, 20–25.
Wender, P. H. (1971). Minimal brain dysfunction in children. New York: Wiley.
Wender, P. H., Reimherr, F. W., and Wood, M. D. (1981). Diagnosis and drug treatment of attention deficit disorder (minimal brain dysfunction) in adults: A replication. Archives of General Psychiatry, 38, 449–456.
Whalen, C. K., Collins, B. E., Henker, B., Alkus, S. R., Adams, D., and Stapp, J. (1978). Behavior observations of hyperactive children and methylphenidate (Ritalin) effects in systematically structured classroom environments: Now you see them; now you don’t. Journal of Pediatric Psychology, 3, 177–187.
Whalen, C. K., Henker, B., and Dotemoto, S. (1981). Teacher response to the methylphenidate (Ritalin) versus placebo status of hyperactive boys in the classroom. Child Development, 52, 1005–1014.
Whalen, C. K., Henker, B., and Finch, D. (1981). Medication effects in the classroom: Three naturalistic indicators. Journal of Abnormal Child Psychology, 9, 419–433.
Whalen, C. K., Henker, B., and Hinshaw, S. P. (1985). Cognitive–behavioral therapies for hyperactive children: Premises, problems, and prospects. Journal of Abnormal Child Psychology, 13, 391–410.
Whalen, C. K., and Henker, B. (1980). The social ecology of psychostimulant treatment: A model for conceptual and empirical analysis. In C. K. Whalen and B. Henker (Eds.), Hyperactive children: The social ecology of identification and treatment (pp. 3–51 ). New York: Academic Press.
Whalen, C. K., and Henker, B. (1984). Hyperactivity and the attention deficit disorders: Expanding frontiers. Pediatric Clinics of North America, 31, 399–427.
Whitehouse, D., Shah, U., and Palmer, F. B. (1980). Comparison of sustained-release and standard methylphenidate in the treatment of minimal brain dysfunction. Journal of Clinical Psychiatry, 41, 282–285.
Woods, D. (1986). The diagnosis and treatment of attention deficit disorder—residual type. Psychiatric Annals, 16, 23–28.
Yellin, A. M. (1986). Psychophysiological correlates of attention deficit disorder. Psychiatric Annals, 16. 29–34.
Zahn, T. P., Rapoport, J. L., and Thompson, C. L. (1980). Autonomic and behavioral effects of dextroamphetamine and placebo in normal and hyperactive prepubertal boys. Journal of Abnormal Child Psychology, 8, 145–160.
Zara, M. M. (1973). Effects of medication on learning in hyperactive four-year-old children. Dissertation Abstracts International, 34, 2407A.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this chapter
Cite this chapter
Brown, R.T., Borden, K.A. (1989). Neuropsychological Effects of Stimulant Medication on Children’s Learning and Behavior. In: Reynolds, C.R., Fletcher-Janzen, E. (eds) Handbook of Clinical Child Neuropsychology. Critical Issues in Neuropsychology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-6807-4_24
Download citation
DOI: https://doi.org/10.1007/978-1-4899-6807-4_24
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-6809-8
Online ISBN: 978-1-4899-6807-4
eBook Packages: Springer Book Archive